ARTICLES ABOUT LUNGS BY DATE - PAGE 5

NEW YORK (Reuters Health) - Using low-dose CT scans to screen high-risk patients for lung tumors is far more effective at preventing lung cancer deaths than scanning those at low risk, according to a new analysis of over 53,000 volunteers. The study, published in the New England Journal of Medicine, comes at a time when doctors are struggling to reduce the death rate among lung cancer patients, who account for more than one quarter of all cancer deaths. An earlier analysis from the National Lung Screening Trial showed that compared to conventional X-rays, screening with low-dose CT scans cut the overall death rate by 20 percent.

With a massive freight yard expansion backed by Mayor Rahm Emanuel poised to bulldoze the northeast corner of Englewood, a new analysis suggests the project would substantially increase lung-damaging pollution in a neighborhood already plagued by high rates of asthma. Based on information provided by Norfolk Southern about diesel-powered locomotives, trucks and equipment at its expanded freight yard, the analysis by the nonprofit Environmental Law and Policy Center found that worrisome levels of soot could spread several blocks beyond the site.

A 6-year-old boy buried for hours under 11 feet of sand at the Indiana Dunes National Lakeshore could be off a ventilator by the end of the week and out of the hospital within two weeks -- a recovery his family hailed as a miracle that has "hit home with us. " "I am firmly convinced that God intervened in this," said the boy's grandfather, the Rev. Don Reul. "In the Bible, you read a lot about the miracles. . .but this hit home with us. I think there are a few sermons that will come out of this.

(Reuters) - The U.S. Food and Drug Administration approved a lung cancer drug made by Boehringer Ingelheim to treat patients who are suffering from late stage non-small cell lung cancer and whose tumors express a specific type of gene mutation. The drug, Gilotrif, was approved along with a companion diagnostic kit that can help determine if a patient's lung cancer cells express the epidermal growth factor receptor (EGFR) gene mutation. Non-small cell lung cancer (NSCLC) is the most common type of lung cancer and represents about 85 percent of all lung cancers.

(Reuters) - A 10-year-old Pennsylvania girl with cystic fibrosis who sparked a national debate about child access to organ donations that led to two lung transplant operations was in recovery on Tuesday after surgery to repair her diaphragm, her family said. Sarah Murnaghan had been left off an adult transplant list because of an age restriction and became eligible only after a judge's order. She had her first lung transplant on June 12, but complications forced a second transplant within days.

NEW YORK (Reuters) - A 10-year-old Pennsylvania girl who sparked a national debate about child access to organ donation took her first independent breath this week on a second set of donor lungs after her first transplant failed, the girl's family said on Friday. Sarah Murnaghan, who had cystic fibrosis and needed a lung transplant, had been kept off an adult organ transplant list due to an age restriction. She became eligible for an adult pair of lungs only after a judge's order.

The Sports Xchange Bruins' Bergeron has punctured lung Boston Bruins center Patrice Bergeron is hospitalized under observation for a punctured lung, general manager Peter Chiarelli told reporters on Wednesday. Chiarelli said the lung injury did not occur during a game but gave no additional details. Bergeron was not at TD Garden with the rest of the team for its end-of-the-season departure on Wednesday. A valiant Bergeron played 17 minutes, 45 seconds in Game 6 of the Stanley Cup Final on Monday night with a broken rib and torn rib cartilage.

(Reuters) - The U.S. Food and Drug Administration approved Theravance Inc's antibiotic lung drug to treat a type of bacterial pneumonia affecting hospitalized patients, particularly those on ventilators. The drug, Vibativ, will reach the market in the third quarter of 2013 for its expanded use. The drug is already approved in the United States and Canada to treat bacterial skin infections. The disease, also known as nosocomial pneumonia, is a serious lung infection as patients, particularly those on ventilators, often cannot fight the infection.